RESEARCH AND DEVELOPMENT EXPENSES	9 Months Ended
Sep. 30, 2011
RESEARCH AND DEVELOPMENT EXPENSES	NOTE 19 – RESEARCH AND DEVELOPMENT EXPENSES On September 6, 2007, SYCI and East China University of Science and Technology formally opened a Co-Op Research and Development Center. The research center is equipped with state of the art chemical engineering instruments for the purpose of pursuing targeted research and development of refined bromide compounds and end products. According to the Co-Op Research Agreement, any research achievement or patents will become assets of the Company. Originally, the Company will provide $500,000 annually until June 2012 to East China University of Science and Technology for research. On June 7, 2011, the Company and East China University of Science and Technology mutually agreed to terminate the Co-op Research Agreement due to the successful completion of the cooperative research and development tasks related to the development of bromine-related chemical products for the Company. Since the second quarter of 2010, SYCI conducted research for the new production line of wastewater treatment additives, the purpose of which is for the testing of the manufacturing routine and samples. The new production line was started operation and normal production in April 2011. However, the Company switched the aforesaid production line to the production of pharmaceutical and agricultural chemical intermediates in mid-June 2011 as the Company experienced some technological limitations on extraction purity, which lead to a lower than expected gross margin for wastewater treatment chemical additives. The research and development expense incurred for the new production line of wastewater treatment additives from outside parties and the consumption of bromine produced by the Company during the three-month period ended September 30, 2011 were $10,135 and $23,429, respectively. The research and development expense incurred for the new production line of wastewater treatment additives from outside parties and the consumption of bromine produced by the Company during the nine-month period ended September 30, 2011 were $43,949 and $66,655, respectively. The total research and development expense recognized in the income statements during the three-month periods ended September 30, 2011 and 2010 were $33,565 and $891,509, respectively. The total research and development expense recognized in the income statements during the nine-month periods ended September 30, 2011 and 2010 were $347,420 and $1,612,862, respectively.

NOTE 19 – RESEARCH AND DEVELOPMENT EXPENSES

On September 6, 2007, SYCI and East China University of Science and Technology formally opened a Co-Op Research and Development Center. The research center is equipped with state of the art chemical engineering instruments for the purpose of pursuing targeted research and development of refined bromide compounds and end products. According to the Co-Op Research Agreement, any research achievement or patents will become assets of the Company. Originally, the Company will provide $500,000 annually until June 2012 to East China University of Science and Technology for research. On June 7, 2011, the Company and East China University of Science and Technology mutually agreed to terminate the Co-op Research Agreement due to the successful completion of the cooperative research and development tasks related to the development of bromine-related chemical products for the Company.

Since the second quarter of 2010, SYCI conducted research for the new production line of wastewater treatment additives, the purpose of which is for the testing of the manufacturing routine and samples. The new production line was started operation and normal production in April 2011. However, the Company switched the aforesaid production line to the production of pharmaceutical and agricultural chemical intermediates in mid-June 2011 as the Company experienced some technological limitations on extraction purity, which lead to a lower than expected gross margin for wastewater treatment chemical additives. The research and development expense incurred for the new production line of wastewater treatment additives from outside parties and the consumption of bromine produced by the Company during the three-month period ended September 30, 2011 were $10,135 and $23,429, respectively. The research and development expense incurred for the new production line of wastewater treatment additives from outside parties and the consumption of bromine produced by the Company during the nine-month period ended September 30, 2011 were $43,949 and $66,655, respectively.

The total research and development expense recognized in the income statements during the three-month periods ended September 30, 2011 and 2010 were $33,565 and $891,509, respectively. The total research and development expense recognized in the income statements during the nine-month periods ended September 30, 2011 and 2010 were $347,420 and $1,612,862, respectively.